Gyon Technologies Capital Management, LP Vaxcyte, Inc. Transaction History

Gyon Technologies Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $116,668 - $271,828	5,669 New	5,669 $271,000
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $479,216 - $720,450	27,105 New	27,105 $590,000
Q1 2022 May 12, 2022	SELL	$17.46 - $26.36 $547,231 - $826,175	-31,342 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$19.32 - $26.45 $605,527 - $828,995	31,342 New	31,342 $746,000

357

123M

775K

433K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.45B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.